NPPB and Patent ductus arteriosus: Despite the rapid fluctuations in NT-proBNP levels during the first days of life, numerous studies have been conducted to evaluate the clinical relevance of BNP/NT-proBNP assays in managing the neonatal patent arterial duct (PDA).